Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR7 | P34969 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | FAP | Q12884 | 1/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11390243 | 0.81 | HSD17B2 (0.48) | HTR2AHTR2CHTR7 | |
| SCHEMBL28565840 | 0.79 | CYP1A2 (0.43) | TRPA1HTR2AHTR2C | |
| SCHEMBL7380899 | 0.79 | BCHE (0.56) | — | |
| SCHEMBL6168501 | 0.76 | DPP4 (0.44) | TRPA1CPA1DPP4DPP8DPP9 | |
| SCHEMBL1044575 | 0.76 | OPRL1 (0.47) | — | |
| SCHEMBL27678768 | 0.76 | ANPEP (0.49) | DPP4 | |
| SCHEMBL8910672 | 0.75 | TRPA1 (0.41) | TRPA1CPA1HTR2AHTR2CHTR7 | |
| SCHEMBL21882278 | 0.73 | TRPA1 (0.54) | TRPA1CPA1IDO1 | |
| SCHEMBL25971517 | 0.72 | EPHX2 (0.43) | CPA1 | |
| SCHEMBL28771486 | 0.72 | TRPA1 (0.52) | TRPA1CPA1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1192165-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | Bristol-Myers Squibb Pharma Company (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000077010-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |